HUMAN ORGAN, TISSUE AND CELL TRANS Sample Clauses

HUMAN ORGAN, TISSUE AND CELL TRANS. PLANTS The Policy includes all required medical and surgical procedures performed on the Insured for the purpose of performing an autologous bone marrow transplant or a cornea transplant on said patient, together with the corresponding administrative procedures. Other transplants or autotransplants of organs, tissue or cells not included in the foregoing de- tail are excluded. Likewise, in all organ trans- plants, medical or surgical procedures to be per- formed on the donor, being he or she an insured party, to remove the organ to be transplanted to the other person, and the procedures related to the conservation and transfer of the organ, are also excluded. - Oncología radioterápica. Incluye cobaltoterapia, braquiterapia, acelerador lineal, los isótopos radio- activos, la radioneurocirugía esterotáxica en los tu- mores intracraneales, y la radioterapia de intensidad modulada cuando estén médicamente indicadas. Se excluye la terapia con haz de protones. - Tratamiento del dolor. Incluye los reservorios im- plantables (port-a-cath), quedando excluidas las bombas implantables para perfusión de medica- mentos y los electrodos de estimulación medular. - Litotricia renal. - Ondas de choque para calcificaciones muscu- lotendinosas. Los tratamientos anteriores, en todos los ca- sos, han de ser prescritos por facultativos del Cuadro Médico de la Aseguradora que tengan a su cargo la asistencia del Asegurado, asistencia que ha de estar cubierta por la Póliza.
AutoNDA by SimpleDocs
HUMAN ORGAN, TISSUE AND CELL TRANS. PLANTS The Policy includes all required medical and sur- gical procedures performed on the Insured for the purpose of performing an autologous bone marrow transplant or a cornea transplant on said patient, together with the corresponding admin- istrative procedures. Other transplants or autotransplants of organs, tissue or cells not included in the foregoing de- tail are excluded. Likewise, in all organ trans- plants, medical or surgical procedures to be per- formed on the donor, being he or she an insured party, to remove the organ to be transplanted to the other person, and the procedures related to the conservation and transfer of the organ, are also excluded.
HUMAN ORGAN, TISSUE AND CELL TRANS. PLANTS The Policy includes all required medical and surgical procedures performed on the Insured for the purpose of performing an autologous bone marrow transplant or a cornea transplant on said patient, together with the corresponding administrative procedures. Other transplants or autotransplants of organs, tissue or cells not included in the foregoing de- tail are excluded. Likewise, in all organ trans- plants, medical or surgical procedures to be per- formed on the donor, being he or she an insured party, to remove the organ to be transplanted to the other person, and the procedures related to the conservation and transfer of the organ, are also excluded.

Related to HUMAN ORGAN, TISSUE AND CELL TRANS

  • Organ Transplants This plan covers organ and tissue transplants when ordered by a physician, is medically necessary, and is not an experimental or investigational procedure. Examples of covered transplant services include but are not limited to: heart, heart-lung, lung, liver, small intestine, pancreas, kidney, cornea, small bowel, and bone marrow. Allogenic bone marrow transplant covered healthcare services include medical and surgical services for the matching participant donor and the recipient. However, Human Leukocyte Antigen testing is covered as indicated in the Summary of Medical Benefits. For details see Human Leukocyte Antigen Testing section. This plan covers high dose chemotherapy and radiation services related to autologous bone marrow transplantation to the extent required under R.I. Law § 27-20-60. See Experimental or Investigational Services in Section 3 for additional information. To speak to a representative in our Case Management Department please call 1-401- 000-0000 or 1-888-727-2300 ext. 2273. The national transplant network program is called the Blue Distinction Centers for Transplants. SM For more information about the Blue Distinction Centers for TransplantsSM call our Customer Service Department or visit our website. When the recipient is a covered member under this plan, the following services are also covered: • obtaining donated organs (including removal from a cadaver); • donor medical and surgical expenses related to obtaining the organ that are integral to the harvesting or directly related to the donation and limited to treatment occurring during the same stay as the harvesting and treatment received during standard post- operative care; and • transportation of the organ from donor to the recipient. The amount you pay for transplant services, for the recipient and eligible donor, is based on the type of service.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Washtenaw Community College Eastern Michigan University Xxxxxx Xxxxxxxxxx College of Engineering & Technology Student Services BE 214 xxx_xxxxxxxx@xxxxx.xxx; 734.487.8659 734.973.3398

  • International Olympic Committee; International Red Cross and Red Crescent Movement As instructed from time to time by ICANN, the names (including their IDN variants, where applicable) relating to the International Olympic Committee, International Red Cross and Red Crescent Movement listed at xxxx://xxx.xxxxx.xxx/en/resources/registries/reserved shall be withheld from registration or allocated to Registry Operator at the second level within the TLD. Additional International Olympic Committee, International Red Cross and Red Crescent Movement names (including their IDN variants) may be added to the list upon ten (10) calendar days notice from ICANN to Registry Operator. Such names may not be activated in the DNS, and may not be released for registration to any person or entity other than Registry Operator. Upon conclusion of Registry Operator’s designation as operator of the registry for the TLD, all such names withheld from registration or allocated to Registry Operator shall be transferred as specified by ICANN. Registry Operator may self-­‐allocate and renew such names without use of an ICANN accredited registrar, which will not be considered Transactions for purposes of Section 6.1 of the Agreement.

  • Mitsui Iron Ore Corporation Pty Ltd. to vary the Iron Ore (Marillana Creek) Agreement;

  • Anti-slavery and human trafficking 22.1 The Supplier shall:

  • India As used herein, “

  • Plagiarism The appropriation of another person's ideas, processes, results, or words without giving appropriate credit.

  • MEDICAL DEVICES This Article applies when the Goods and/or Services involve UC purchasing or leasing one or more medical devices from Supplier, or when Supplier uses one or more medical devices in providing Goods and/or Services to UC. Medical Device as used herein will have the meaning provided by the U.S. Food and Drug Administration (“FDA”) and means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: (i) recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them; (ii) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (iii) intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes. Supplier warrants that prior to UC’s purchase or lease of any Medical Device or Supplier’s use of any Medical Device in providing Goods and/or Services hereunder, Supplier will: (i) perform security testing and validation for each such Goods and/or Services or Medical Device, as applicable; (ii) perform a security scan by an anti-virus scanner, with up-to-date signatures, on any software embedded within any Goods and/or Services or Medical Device, as applicable, in order to verify that the software does not contain any known viruses or malware; (iii) conduct a vulnerability scan encompassing all ports and fuzz testing; and (iv) provide UC with reports for (i) – (iii). Supplier warrants that all security testing performed by Supplier covers all issues noted in the “SANS WE TOP 25” and/or “OWASP Top 10” documentation. Throughout Supplier’s performance of this Agreement, Supplier will provide UC with reasonably up-to-date patches, firmware and security updates for any Medical Device provided to UC, and any other Medical Device used in the course of providing Services, as applicable. All such patches and other security updates will be made available to UC within thirty (30) days of its commercial release or as otherwise recommended by Supplier or Supplier’s sub-supplier, whichever is earlier. Supplier warrants that all software and installation media not specifically required for any Medical Device used by Supplier or Goods and/or Services delivered to UC under this Agreement as well as files, scripts, messaging services and data will be removed from all such Goods and/or Services or Medical Device following installation, and that all hardware ports and drives not required for use or operation of such Goods and/or Services or Medical Device will be disabled at time of installation. In addition, Medical Devices must be configured so that only Supplier-approved applications will run on such Medical Devices. Supplier agrees that UC may take any and all actions that it, in its sole discretion, deems necessary to address, mitigate and/or rectify any real or potential security threat, and that no such action, to the extent such action does not compromise device certification, will impact, limit, reduce or negate Supplier’s warranties or any of Supplier’s other obligations hereunder. Supplier warrants that any Medical Device provided to UC, and any other Medical Device used in the course of providing such Goods and/or Services, meet and comply with all cyber-security guidance and similar standards promulgated by the FDA and any other applicable regulatory body. If the Goods and/or Services entail provision or use of a Medical Device, Supplier will provide UC with a completed Manufacturer Disclosure Statement for Medical Device Security (MDS2) form for each such Medical Device before UC is obligated to purchase or lease such Medical Device or prior to Supplier’s use of such device in its performance of Services. If Supplier provides an MDS2 form to UC concurrently with its provision of Goods and/or Services, UC will have a reasonable period of time to review such MDS2 form, and if the MDS2 form is unacceptable to UC, then UC in its sole discretion may return the Goods or terminate the Agreement with no further obligation to Supplier.

  • Destination CSU-Pueblo scholarship This articulation transfer agreement replaces all previous agreements between CCA and CSU-Pueblo in Bachelor of Science in Physics (Secondary Education Emphasis). This agreement will be reviewed annually and revised (if necessary) as mutually agreed.

Time is Money Join Law Insider Premium to draft better contracts faster.